Cytokinetics CEO Gifts 2,000 Shares of Company Stock
CYTOKINETICS INC
Subscribe to track CYTK
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Cytokinetics CEO Gifts 2,000 Shares of Company Stock
Company: CYTOKINETICS INC (CYTK) Form: 4 | Filed: 2025/11/05 Significance: Low
Insider: Blum Robert I Title: President & CEO | Relationship: Director, Officer
Transaction: • Type: Gift • Shares: 2,000 • Price: $0.00 • Value: $0 • Owned After: 356,108 (Directly)
Key Insight: This is a minor gift transaction by the CEO, representing a negligible percentage of shares outstanding and having no direct market value. Such transactions are typically for personal or estate planning and are not considered significant market signals.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: CYTOKINETICS INC (CYTK)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The President & CEO, Robert I. Blum, made a gift of 2,000 shares of common stock, a transaction with no monetary value and minimal impact on his overall holdings.
- Market Impact: Neutral. This transaction is not expected to have any impact on the stock price or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | CYTOKINETICS INC |
| Ticker Symbol | CYTK |
| CIK | 0001061983 |
| Industry | PHARMACEUTICAL PREPARATIONS |
Insider Information
| Field | Value |
|---|---|
| Name | Blum Robert I |
| CIK | 0001288859 |
| Title/Position | President & CEO |
| Relationship | Director, Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-05 |
| Transaction Code | G (Gift) |
| Security Type | Common Stock |
| Shares Involved | 2,000 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 356,108 (Directly) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $0 |
| % of Market Cap | 0.00% |
| Shares Transacted | 2,000 |
| % of Shares Outstanding | 0.0017% |
| Post-Transaction Ownership | 360,274 shares (0.30% of outstanding, including indirect holdings) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: Cytokinetics has a market capitalization of $7.61 billion. The transaction value is $0, making it immaterial.
- Ownership Concentration: The 2,000 shares gifted represent a very small fraction of the CEO's total direct and indirect holdings of 360,274 shares. His ownership stake remains low at approximately 0.30%.
- Transaction Significance: The transaction is a gift (Code G), which is a disposition of shares for no value. It constitutes a negligible 0.0017% of the total shares outstanding, categorizing its significance as Low.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Gift transactions are typically for personal financial or estate planning and do not reflect an insider's sentiment on the company's future performance. The size is insignificant relative to the company's market cap and public float.
Volume & Sentiment
- Expected Volume Impact: None. The transaction is too small to influence trading volume.
- Sentiment Indicator: Neutral. The filing does not provide any bullish or bearish signals.
Additional Context
Transaction Notes
- The filing indicates a disposition of 2,000 shares via a gift. The footnotes detail indirect holdings in two separate trusts for family members.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
